It has been reported that CVB-D improves DCM via inhibition of cardiomyocyte pyroptosis through the NLRP3/caspase-1/GSDMD pathway and reduces HG-induced pyroptosis in PNRCMs [128]. Here, NLRP3 is linked to familial dilated cardiomyopathy.